Michael F. Brigham
Net Worth

Last updated:

What is Michael F. Brigham net worth?

The estimated net worth of Mr. Michael F. Brigham is at least $8,707,673 as of 28 Dec 2018. He owns shares worth $913,733 as insider and has received compensation worth at least $7,793,940 in ImmuCell Corporation.

What is the salary of Michael F. Brigham?

Mr. Michael F. Brigham salary is $354,270 per year as Pres, Chief Executive Officer, Principal Financial Officer, Treasurer, Sec. & Director in ImmuCell Corporation.

How old is Michael F. Brigham?

Mr. Michael F. Brigham is 64 years old, born in 1961.

What stocks does Michael F. Brigham currently own?

As insider, Mr. Michael F. Brigham owns shares in one company:

Company Title Shares Price per share Total value
ImmuCell Corporation (ICCC) Pres, Chief Executive Officer, Principal Financial Officer, Treasurer, Sec. & Director 154,870 $5.9 $913,733

What does ImmuCell Corporation do?

ImmuCell Corporation, an animal health company, develops, manufactures, and markets products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. It offers First Defense, an orally delivered scours preventive product for newborn dairy and beef calves; and Tri-Shield First Defense, a passive antibody product for the treatment of E. coli, coronavirus, and rotavirus. The company also provides California Mastitis Test that is used to detect somatic cell counts in milk, as well as to determine, which quarter of the udder is mastitic; and Dual-Force First Defense, including a whey protein concentrate for the nutritional and feed supplement markets. In addition, it is involved in developing Re-Tain, a Nisin-based intramammary treatment of subclinical mastitis in lactating dairy cows. It sells its products through animal health distributors. ImmuCell Corporation was incorporated in 1982 and is headquartered in Portland, Maine.

ICCC logo
ICCC
ImmuCell Corporation
$5.9

Michael F. Brigham insider trading

ImmuCell Corporation

Transaction Date Security Shares Price per share Total value Source
Option
Common Stock, par value $0.10 per share 47,500 $1.7 $80,750
Option
Incentive Stock Options (Right to buy) 47,500 $1.7 $80,750
Option
Common Stock, par value $0.10 per share 1,000 $5.25 $5,250
Option
Incentive Stock Options (Right to buy) 1,000 $5.25 $5,250
Option
Incentive stock options (right to buy) 1,000 $3.1 $3,100
Option
Common Stock, par value $0.10 per share 1,000 $3.1 $3,100
Option
Common Stock 1,000 $3.2 $3,200
Option
Incentive stock options (right to buy) 1,000 $3.2 $3,200
Purchase
Common Stock, par value $0.10 per share 1,000 $2 $2,000
Purchase
Common Stock, par value $0.10 per share 51,000 $1.31 $66,963
Purchase
Common stock, par value $0.10 per share 388 $3.27 $1,269
Purchase
Common stock, par value $0.10 per share 612 $3.27 $2,001
Purchase
Common stock, par value $0.10 per share 500 $3.74 $1,870
Option
Common Stock, par value $0.10 per share 12,000 $4 $48,000
Option
Incentive stock options (right to buy) 12,000 $4 $48,000
Option
Common Stock, par value $0.10 per share 500 $1.69 $844
Option
Incentive stock options (right to buy) 500 $1.69 $844
Option
Common Stock, par value $0.10 per share 10,500 $1.94 $20,349
Option
Incentive stock options (right to buy) 10,500 $1.94 $20,349
Option
Incentive stock options (right to buy) 6,500 $1.38 $8,938
Option
Common Stock, par value $0.10 per share 6,500 $1.38 $8,938

ImmuCell key executives

ImmuCell Corporation executives and other stock owners filed with the SEC: